We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
CarMax
KMX
$8.26B
| $30.3M | 0.01% |
497,559
-1,332,186
| -73% | -$85.5M |
|
777
Planet Fitness
PLNT
$3.78B
| $30.3M | 0.01% |
384,105
+85,713
| +29% | +$5.98M |
|
778
Fortune Brands Innovations
FBIN
$6.06B
| $30.3M | 0.01% |
529,866
-155,387
| -23% | -$8.17M |
|
779
Enterprise Products Partners
EPD
$81.7B
| $30.2M | 0.01% |
1,253,552
+68,824
| +6% | +$1.69M |
|
780
Brown-Forman Class B
BF.B
$13.1B
| $30.2M | 0.01% |
459,416
-7,394
| -2% | -$502K |
|
781
HEICO Corp Class A
HEI.A
$37.2B
| $30.1M | 0.01% |
251,375
+5,541
| +2% | +$676K |
|
782
Televisa
TV
$1.49B
| $30.1M | 0.01% |
6,597,888
+209,184
| +3% | +$1.08M |
|
783
Extreme Networks
EXTR
$3.15B
| $30M | 0.01% |
1,640,838
+265,447
| +19% | +$4.65M |
|
784
Marriott Vacations Worldwide
VAC
$4.25B
| $30M | 0.01% |
222,942
+20,267
| +10% | +$2.83M |
|
|
LADR
785
Ladder Capital
LADR
$1.24B
| $30M | 0.01% |
2,984,417
+707,895
| +31% | +$7.34M |
|
786
Otter Tail
OTTR
$3.94B
| $30M | 0.01% |
510,157
-17,982
| -3% | -$1.08M |
|
787
Assurant
AIZ
$14.3B
| $29.9M | 0.01% |
239,465
+83,424
| +53% | +$11.1M |
|
788
Adient
ADNT
$1.5B
| $29.9M | 0.01% |
861,323
-46,258
| -5% | -$1.62M |
|
789
VF Corp
VFC
$5.89B
| $29.9M | 0.01% |
1,081,841
-10,735
| -1% | -$316K |
|
790
EPR Properties
EPR
$4.77B
| $29.7M | 0.01% |
788,691
+69,767
| +10% | +$2.72M |
|
791
Dell
DELL
$293B
| $29.7M | 0.01% |
737,866
-21,759
| -3% | -$860K |
|
792
FIVE9
FIVN
$2.54B
| $29.6M | 0.01% |
436,687
-172,907
| -28% | -$10.9M |
|
793
Neurocrine Biosciences
NBIX
$16.6B
| $29.6M | 0.01% |
247,821
-32
| -0% | -$3.75K |
|
|
RXDX
794
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $29.5M | 0.01% |
268,619
-66,061
| -20% | -$4.28M |
|
795
ITT
ITT
$19.1B
| $29.4M | 0.01% |
362,184
+10,123
| +3% | +$784K |
|
796
Parsons
PSN
$5.08B
| $29.4M | 0.01% |
634,695
-34,689
| -5% | -$1.6M |
|
797
First Financial Bankshares
FFIN
$4.97B
| $29.3M | 0.01% |
853,014
-29,700
| -3% | -$1.12M |
|
798
ADMA Biologics
ADMA
$2.22B
| $29.3M | 0.01% |
7,552,507
-1,151,226
| -13% | -$3.55M |
|
799
Sabre
SABR
$835M
| $29.1M | 0.01% |
4,714,662
+638,976
| +16% | +$3.57M |
|
800
Omega Healthcare
OHI
$14.7B
| $29.1M | 0.01% |
1,041,707
+501,780
| +93% | +$15.1M |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.